Tsujimura, Kazuma <br/><br/>
Is Efficacy of the Anti-Cd20 Antibody Rituximab Preventing Hemolysis Due to Passenger Lymphocyte Syndrome?  [electronic resource] 

 -  Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy  Feb 2017 
 - 22-25 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1744-9987 
<br/><br/><label>Standard No.: </label>10.1111/1744-9987.12483  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>ABO Blood-Group System--blood<br/>Blood Group Incompatibility--blood<br/>Female<br/>Hemolysis<br/>Humans<br/>Immunologic Factors--immunology<br/>Kidney Transplantation<br/>Lymphocytes--immunology<br/>Male<br/>Rituximab--immunology<br/>Syndrome<br/>Tissue Donors<br/>Treatment Outcome